CIPLA FDA Approval ANDA 090561

ANDA 090561

CIPLA

FDA Drug Application

Application #090561

Documents

Letter2010-11-03

Application Sponsors

ANDA 090561CIPLA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL300MG0ZIDOVUDINEZIDOVUDINE

FDA Submissions

ORIG1AP2010-10-27
LABELING; LabelingSUPPL5AP2012-10-25STANDARD
LABELING; LabelingSUPPL7AP2020-02-07STANDARD
LABELING; LabelingSUPPL8AP2020-02-07STANDARD
LABELING; LabelingSUPPL10AP2020-02-07STANDARD
LABELING; LabelingSUPPL12AP2020-02-07STANDARD
LABELING; LabelingSUPPL13AP2020-02-07STANDARD

Submissions Property Types

ORIG1Null1
SUPPL5Null1
SUPPL7Null7
SUPPL8Null15
SUPPL10Null7
SUPPL12Null7
SUPPL13Null7

TE Codes

001PrescriptionAB

CDER Filings

CIPLA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90561
            [companyName] => CIPLA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZIDOVUDINE","activeIngredients":"ZIDOVUDINE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ZIDOVUDINE","submission":"ZIDOVUDINE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.